- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide
Total 1120 results
-
National Cancer Institute (NCI)RecruitingAcute Adult T-Cell Leukemia/Lymphoma | Adult T-Cell Leukemia/Lymphoma | Chronic Adult T-Cell Leukemia/Lymphoma | HTLV-1 InfectionUnited States
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Jiangsu Province... and other collaboratorsRecruiting
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
Peking Union Medical College HospitalPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruiting
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Nanchang University; RenJi Hospital; Ningbo... and other collaboratorsRecruitingRecurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)China
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Peking Union Medical College HospitalPeking University First Hospital; Beijing Tiantan Hospital; Chinese PLA General... and other collaboratorsRecruitingPrimary Central Nervous System LymphomaChina
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Beijing Friendship HospitalRecruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Janssen, LPRecruitingMultiple MyelomaUnited States, Canada
-
Larysa SanchezJanssen, LPRecruitingNewly Diagnosed Multiple MyelomaUnited States
-
Belarusian Research Center for Pediatric Oncology...Recruiting
-
St. Joseph's Hospital and Medical Center, PhoenixThe Cleveland Clinic; National Institute on Aging (NIA)RecruitingCognitive Dysfunction | Neurodegeneration | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, BrainUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruitingFollicular LymphomaUnited States, Australia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Shandong Provincial HospitalRecruitingHematologic Neoplasms | Multiple Myeloma | Efficacy | SafetyChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed LymphomaChina
-
University of Turin, ItalyRecruiting
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
Peking Union Medical College HospitalRecruitingPrimary Intraocular LymphomaChina
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
University of ChicagoRecruiting
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Kosin University Gospel HospitalRecruitingWaldenström's MacroglobulinemiaKorea, Republic of
-
University Hospital, ToulouseRecruiting
-
CelgeneRecruitingLymphoma, Mantle-CellSpain, Italy, Germany, Austria, France, Greece, Netherlands
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
University of ChicagoJanssen Scientific Affairs, LLC; AmgenRecruitingMultiple Myeloma | MyelomaUnited States
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingPrimary Central Nervous System LymphomaDenmark, Finland, Italy, Israel, Switzerland
-
National Cancer Institute (NCI)RecruitingRecurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
CelgeneRecruiting
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSezary Syndrome | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Folliculotropic Mycosis Fungoides | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Cutaneous...United States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
National Cancer Institute (NCI)Active, not recruitingPrimary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS) | Aggressive B-cell Lymphoma With Secondary Involvement of the CNSUnited States
-
GenmabAbbVieActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell LymphomaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Leukemia | Plasma Cell Myeloma | B-Cell Non-Hodgkin Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States